SDHA and prostate cancer: Their study on oxidative phosphorylation capacities in prostate cancer tissues uncovered increased oxidation of succinate via Complex II as compensation for a decreased capacity to oxidize substrates via Complex I. In our cohort of HNSCC patients, the increased SDHA expression might also be associated with an increased oxidative phosphorylation capacity which might confer radiation resistance.